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The aim of this study was to analyze the impact of a community-based exercise program in primary care on inflammatory
biomarkers and hormone levels. The 1-year quasiexperimental study involved 13 women (mean age = 56.8 ± 11.4 years) and it
was developed in two basic health care units in Rio Claro City, Brazil. The physical exercise intervention was comprised of two, 60-
minute sessions/week.The inflammatory biomarkers were measured at baseline, 6 months, and 1 year. Repeated measures ANOVA
analyses indicated that the intervention was effective in reducing CRP and TNF𝛼 after 1 year compared to baseline and 6 months
(𝑃 < 0.05). There were no changes in IL10, IL6, and insulin after 1 year. However, leptin significantly increased at 1 year (𝑃 = 0.016).
Themajor finding of this study is that a community-based exercise program can result in a decrease ormaintenance of inflammatory
biomarkers after 1 year, and thus has the potential to be a viable public health approach for chronic disease prevention.
1. Introduction
It is well established that chronic diseases are the leading
cause of mortality in the world. According to the World
Health Organization [1] 60% of all death is attributed
to cardiovascular diseases, diabetes, cancers, and chronic
respiratory diseases. The inflammatory process related to
chronic diseases, characterized by dysregulation in the
balance between pro- and anti-inflammatory processes, is
linked with several complications such as insulin resistance,
endothelial dysfunction, atherosclerosis, and vascular and
metabolic disorders [2–5].
Regular physical exercise has been increasingly viewed
as an effective therapeutic strategy for the management of
chronic diseases [6]. It has long been known that regular
physical activity induces multiple adaptations within skeletal
muscles and the cardiorespiratory system, providing posi-
tive outcomes for the prevention and treatment of chronic
diseases [7, 8]. Some studies have indicated that regular
physical activity has anti-inflammatory effects and is asso-
ciated with improvement in inflammatory biomarkers such
as a reduction in levels of the proinflammatory cytokines
[9–14]. According to Pedersen [8], the anti-inflammatory
processes provided by physical exercise play important roles
in the protection against diseases associated with low-grade
inflammation such as cardiovascular diseases and type 2
diabetes.
Considering that physical inactivity is the fourth leading
cause of death worldwide [15] and causes 6–10% of the
major noncommunicable diseases [6], it is necessary to
induce social, economic, and environmental changes and
multiple strategies that promote public policies related to
physical active life style. “Sau´de Ativa Rio Claro” (SARC)
is a community-based exercise intervention in primary care
designed to promote and maintain physical activity levels
of residents in Rio Claro City, Brazil. Since 2001, SARC
operates in basic health care units and reaches approximately
400 low-income adults aged 35 years or older [16]. Evidence
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Figure 1: Recruitment of participants for the study. Evaluationswere
done at baseline, 6 months, and 1 year of SARC intervention.
suggests that this program improves blood cholesterol, LDL,
HDL, and glucose profiles [17, 18]. However, it is unknown
whether the SARC intervention can improve inflammatory
biomarkers and thus potentially aid in the prevention of
chronic disease and associated complications. Therefore, the
aim of this study was to assess the impact of SARC on a
range of common inflammatory biomarkers and hormone
levels in adult women, including leptin, insulin, C-reactive
protein (CRP), interleukin 6 (IL6), tumor necrosis factor
alpha (TNF𝛼), and interleukin 10 (IL10). It was hypothesized
that there would be an increase in IL10 and a decrease in
inflammatory markers (CRP, IL6, and TNF𝛼) and hormone
(leptin and insulin) levels after 1 year of SARC intervention.
2. Methods
2.1. Participants. This 1-year quasiexperimental study was
developed in two basic health care units in Rio Claro City,
Brazil. Adult females were recruited via flyers and newspaper
advertisements. Participants were assigned to the interven-
tion group based upon proximity from their residence.
Thirty-six participants were recruited at the beginning of
intervention. As a result of either voluntary dropout or failure
to meet the inclusion criterion for the study (frequency of
75% attendance in the sessions), 25 participants remained
in the intervention after 6 months. Although 17 participants
completed the 1 year intervention, four participants did not
complete all evaluations; thus the final sample size was 13
women (mean age = 56.8 ± 11.4 years, Figure 1). The study
was approved by the Human Research Ethics Committee of
Biosciences Institute, UNESP, protocol number: 2308.
2.2. Physical Exercise Intervention. SARC is a community-
based exercise intervention comprised of two 60-minute
sessions/week of physical exercises.The sessionswere divided
in warm-up activities (5 minutes), moderate intensity aer-
obic exercise (30 minutes), strength-training exercises (20
minutes), and cool-down activities (5minutes). Furthermore,
during each session, the participants received counseling
designed to increase daily physical activity levels and encour-
age participation in physical exercise outside of the interven-
tion.
The warm-up and cool-down activities included static
stretching exercises and articular movements. Static stretch-
ingwasmaintained for aminimumperiod of 15 to 30 seconds,
twice for eachmuscle group.The participants were advised to
sustain a muscle stretch that did not cause pain [19, 20]. The
aerobic exercises consisted of walking at moderate intensity
(60–70% of peak heart rate). The target zone for exercise was
calculated using the equationHRpeak = 206− (0.88× age), as
suggested byGulati et al. [21]. All participants were instructed
to maintain a subjective effort between 13 and 15 [22] on
the Borg scale [23] during walking. Four participants were
randomly selected to measure the intensity of their activity
twice a month using a cardiac rate monitor (Polar, FS1) and
the subjective effort scale. The strength-training exercises
were performed using free weights, exercise mats, and latex
exercise bands. Exercises included all major muscle groups
and were performed in 3 sets of 30 seconds, followed by one
minute of recovery.
2.3. Inflammatory Biomarkers Measures. A 10mL venous
blood sample was collected at baseline, after 6 months, and
after 1 year of intervention, in the morning after 12 hours
of fasting. The blood sample was transported under refrig-
eration to the laboratory within 30 minutes, centrifuged for
10 minutes with the serum immediately separated following
centrifugation. The inflammatory biomarkers were analyzed
in duplicate using commercial kits. C-reactive protein (CRP)
was analyzed using an enzyme-linked immunosorbent assay
(ELISA). Interleukin 10 (IL10), interleukin 6 (IL6), tumor
necrosis factor alpha (TNF𝛼), leptin, and insulin were ana-
lyzed using Luminex technology assay (Luminex). Intra-
assay coefficients were all <10%. To minimize analytical
variations, the same technician tested all samples without
changing reagent lots, standards, or control materials.
2.4. Statistical Analyses. Descriptive data are reported as
means and standard deviations. The ratio of IL-10 to TNF-𝛼
(IL10/TNF-𝛼) was calculated and compared in 1 year.
A repeated measures ANOVA was used to analyze the
changes in anthropometric variables, inflammatory biomark-
ers, and hormones levels over time (baseline, 6 months, and 1
year). Significant differences were determined by Bonferroni
post hoc tests. Statistical analyses were conducted using SPSS
20.0, with the alpha level set at 𝑃 < 0.05.
3. Results
Table 1 shows the anthropometric characteristics of the par-
ticipants (𝑛 = 13, mean age of 56.8 ± 11.4) at baseline, 6
months, and 1 year. No changes in weight, body mass index
(BMI), or waist to hip ratio (WHR) were seen over time (𝑃 >
0.05).Theprevalence of diseaseswas 7.7% (𝑛 = 1) for diabetes,
30.7% (𝑛 = 4) for obesity, and 38.5% for hypertension (𝑛 = 5).
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Table 1: Anthropometric characteristics (mean, standard deviation) of participants at baseline, after 6 months, and after 1 year of exercise
intervention.
Baseline 6 months 1 year 𝑃 valueBL versus 6M
𝑃 value
BL versus 1 Y
𝑃 value
6M versus 1 Y
Weight (kg) 67.3 ± 11.5 66.8 ± 11.4 67.2 ± 10.9 0.541 0.631 1.000
BMI (kg/m2) 27.5 ± 5.6 26.8 ± 6.0 27.9 ± 5.6 0.500 0.316 1.000
WHR 0.88 ± 0.8 0.86 ± 0.8 0.89 ± 0.7 0.863 0.326 1.000
BL: baseline; 6M: 6 months; 1 Y: 1 year; BMI: body mass index; WHR: waist and hip ratio.
Table 2: Inflammatory biomarkers and hormone concentration levels (mean, standard deviation) at baseline, after 6 months, and after 1 year
of exercise intervention.
Biomarker BL 6M 1Y 𝑃 valueBL versus 6M
𝑃 value
BL versus 1 Y
𝑃 value
6M versus 1 Y
CRP (mg⋅L−1) 3.4 ± 1.2 3.0 ± 1.2 1.5 ± 1.0∗𝛼 0.999 0.001 0.003
IL10 (pg⋅mL−1) 4.8 ± 2.0 4.4 ± 2.3 4.2 ± 1.5 0.988 0.681 0.602
IL6 (pg⋅mL−1) 4.4 ± 1.1 4.2 ± 1.5 3.4 ± 0.7 0.999 0.236 0.163
TNF𝛼 (pg⋅mL−1) 10.6 ± 5.6 7.6 ± 4.0 5.6 ± 3.0∗𝛼 0.082 0.001 0.004
Leptin (ng/mL−1) 2.69 ± 2.25 2.30 ± 1.66 7.60 ± 4.89∗𝛼 0.999 0.016 0.003
Insulin (ng/mL−1) 1.09 ± 1.01 0.83 ± 0.41 0.67 ± 0.17 0.898 0.405 0.642
IL10/TNF𝛼 0.59 ± 0.4 0.64 ± 0.2 0.85 ± 0.3 — — —
BL: baseline; 6M: 6 months; 1 Y: 1 year; CRP: C-reactive protein; IL10: interleukin 10; IL6: interleukin 6; TNF𝛼: tumor necrosis factor alpha.
∗Statistically significant difference from baseline.
𝛼Statistically significant difference after 6 months.
The prevalence of participants having at least 1 disease was
46.1% (𝑛 = 6).
Table 2 and Figure 2 illustrate the inflammatory biomark-
ers and hormone concentration levels and indicate the
outcomes of statistical analyses between time at baseline, 6
months, and 1 year. CRP levels significantly decreased after 1
year of intervention (1.5 ± 1.0mg⋅L−1) compared to baseline
(3.4 ± 1.2mg⋅L−1, 𝑃 = 0.001) and 6 months (3.0 ± 1.2mg⋅L−1,
𝑃 = 0.003). A significant decrease in TNF𝛼 levels was shown
after 1 year of intervention (56.6 ± 3.0 pg⋅mL−1) compared
to baseline (10.6 ± 5.6 pg⋅mL−1, 𝑃 = 0.001) and 6 months
(7.6 ± 4.0 pg⋅mL−1, 𝑃 = 0.004). IL10, IL6, and insulin did not
change over 1 year (𝑃 > 0.05). Leptin levels were significantly
increased after 1 year (7.6 ± 4.89 pg⋅mL−1) of intervention
compared to baseline (2.69 ± 2.25 pg⋅mL−1, 𝑃 = 0.016) and 6
months (2.3±1.66 pg⋅mL−1,𝑃 = 0.003).The IL10/TNF𝛼 ratio
increased after 1 year of intervention (BL = 0.59 ± 0.4; 6M =
0.64 ± 0.2; 1 Y = 0.85 ± 0.3).
4. Discussion
Chronic inflammation is an important pathophysiological
factor in the development of several diseases and complica-
tions, through the effects of proinflammatory cytokines such
as TNF𝛼 and IL6, among others [2–5]. On the contrary, anti-
inflammatory cytokines, such as adiponectin and IL-10, seem
to be protective against pathological conditions [24, 25].
Analyses indicate that the SACR intervention was effec-
tive in decreasing CRP and TNF𝛼 levels and maintaining
IL10, IL6, and insulin levels over 1 year. However, lep-
tin levels increased over 1 year. Several studies show that
inflammatory biomarkers are reduced following longer term
lifestyle modification involving reduced food intake and
increased physical activity [9]. Thus, the effects of regular
physical activity on basal levels of inflammatorymarkers have
been used to recommend exercise as an anti-inflammatory
therapy. According to Soares and de Souza [14] integrative
interventions, including diet, moderate aerobic exercise (60%
to 80% of HRmax or 50% to 60% of VO
2max) and circuit
resistance training (8 to 10 exercises, 8 to 12 repetitions),
health education, and counseling, used together, appeared to
be effective strategies to improve inflammatory biomarkers in
women.
Our results (Table 2 and Figure 2) indicated that SARC
was effective in decreasing CRP levels after 1 year compared
to baseline and 6 months. These findings are in agreement
with other studies in the literature indicating that a physical
lifestyle can reduce CRP levels [13, 26–29]. CRP has a long
plasma half-life (>96 h), no variation of diurnal or seasonal,
and no age or gender dependence [30, 31]. It plays a pivotal
role in the innate immune response, is released in response
to a variety of proinflammatory cytokines, and is triggered
by many factors such as cardiovascular diseases, trauma,
malignancy, and chronic arthritis [32]. In our study, the
56% decrease in CRP is clinically relevant because the value
changed from a level considered “high risk” for cardiovascu-
lar disease at baseline (above 3.0mg/L) to an “average risk”
(1.0 to 3.0 mgL) after 1 year of the SARC intervention.
According to You et al. [33], findings about the relation-
ship between physical exercise and inflammatory biomarkers
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Figure 2: Levels of C-reactive protein (CRP), interleukin 10 (IL10), interleukin 6 (IL6), tumor necrosis factor alpha (TNF𝛼), leptin, and
insulin at baseline, after 6 months, and after 1 year of exercise intervention. ∗Statistically significant difference from baseline. 𝛼Statistically
significant difference from 6 months.
are more consistent for CRP than for other biomarkers.
However, the SARC intervention was effective in reducing
TNF𝛼 (Table 2 and Figure 2) after 1 year compared to baseline
and after 6 months. Studies have indicated that regular
physical activity is associated with a reduction or no change
in TNF𝛼 [27, 28, 34, 35]. TNF-𝛼 is a cytokine with a varied
range of proinflammatory activities, such as influencing the
atherosclerotic process both by causing metabolic perturba-
tions and by increasing the expression of cellular adhesion
molecules [36].
No changeswere detected in IL10 following 1 year of inter-
vention (Table 2). IL10 has multifaceted anti-inflammatory
properties. It is able to reduce serum levels of TNF𝛼 and IL6
and plays a protective role against atherosclerosis [24, 25].
There is lack of consensus in the literature as to whether
physical activity can improve IL10 levels. Kadoglou et al. [28]
demonstrated in their study that a higher volume of aerobic
exercise (four times/week, 45–60min/session) was effective
in increasing IL10 levels after 6 months. Similarly, Jankord
and Jemiolo [37] compared groups performing different
amounts of physical activity volume and concluded that the
higher volume was associated with an increase of IL-10 [37].
Thus, it appears that 2 sessions per week of physical exercise
delivered by SARC may be insufficient to improve IL10
levels. However, the IL10/TNF𝛼 ratio increased after 1 year of
intervention. This result indicates that physical exercise was
able to improve the proportion of anti- to proinflammatory
cytokines after 1 year.
The SARC intervention did not change IL6 levels fol-
lowing 1 year of intervention (Table 2). Some studies have
reported that physical exercise is correlated with lower
IL6 levels [13, 29, 34, 37–40]. However, our results are in
agreement with other studies. Olson et al. [41] found that
an intervention consisting of at least two training sessions
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per week was not effective in reducing IL6 levels after 1 year.
Campbell et al. [42] and Donges et al. did not also find
lower levels of IL6 following physical exercise interventions
[43]. Different cells produce IL6 and this cytokine plays both
“good” and “bad” roles depending on the circumstances.
It has been suggested that an elevation in IL6 in response
to physical exercise can exert an anti-inflammatory role.
Myokine, the IL6 from muscle, can increase during physical
exercise. It wields metabolic effects on liver and adipose
tissues (activating glycogenolysis and lipolysis) and inhibits
the production of TNF𝛼 [44, 45]. On the other hand, IL6 is
also secreted by macrophages and lymphocytes in response
to injury or infection [46] and has been associated with
several pathological conditions as a marker of low-grade
inflammation [47, 48]. Thus, the maintenance of IL6 levels
during a 1-year intervention could be considered a positive
outcome.
It is currently well accepted that regular physical exercise
is an effective therapeutic intervention to reduce the risk of
developing insulin resistance by improving glucose tolerance
and insulin action in individuals predisposed to developing
type 2 diabetes [7]. It has been hypothesized that insulin
resistance increases with age due to increased adiposity,
decreased lean muscle mass, changes in dietary habits, and
reduced physical activity [49]. Although there was not a
statistically significant change in insulin in the present study
(Table 2), insulin levels decreased by 38.4% after 1 year of
the intervention, suggesting that insulin sensitivity may have
improved, although an insulin sensitivity test in participants
would be needed to confirm this.
In the present study, leptin levels were maintained until
6 months and then increased significantly after 1 year of the
intervention (Table 2 and Figure 2). Despite these changes,
leptin levels remained in the normal range (2.5–21.8 ng/mL).
According to Mota and Zanesco [50], the relationship
between physical activity and plasma leptin is unclear, with
some studies showing a reduction in their levels while
others fail to find any change. Recently, Akbarpour [13]
demonstrated that 12 weeks of physical exercise was able to
reduce leptin levels, BMI, and IL6, and in contrast to our
findings they did not find any changes in TNF𝛼.
Plasma levels of leptin can increase as the result of
obesity [51]; in the present study we saw no changes in
body weight, BMI, or WHR after 1 year. In addition, TNF-
𝛼 and CRP have been shown to be related to high levels
in adipose tissue, and its level in the circulation indicates
the production of these biomarkers in adipose tissue [51].
In the present study, although no decrease in BMI and
weight was observed, the levels of TNF𝛼 and CRP were
decreased, supporting the effect of exercise on these biomark-
ers independent of weight loss. Current evidence supports
that exercise training reduces chronic inflammation and this
effect is independent of the exercise induced weight loss
[33].
The mechanisms related to physical exercise as a therapy
in changing inflammatory biomarkers are not clear, despite
studies showing positive outcomes.The discrepancy between
the results from various studies in the literature can be
attributed to the differences among the groups studied,
training period, volume, intensity, duration, and type of
training.
This study has a number of limitations that should be
considered. The small sample size that resulted in the study
has low statistical power and was a result of the difficulty
in maintaining a 75% participation rate in the intervention
sessions over the 1-year intervention period. We attempted to
reduce dropout by assigning participants to an intervention
groups geographically near their home. In addition, this study
employed a quasiexperimental design, and thus we are not
able to statewith confidence that the changes in inflammatory
markers are due to participation in the SARC intervention.
We attempted to include a control group (doing no physical
exercise over 1 year) to allow us to conduct a controlled trial,
but the university ethics committee would not approve this
study design.
Considering the fact that 46.1% of participants already
had at least 1 disease related with the inflammation process,
this study illustrates that a public health exercise intervention
delivered in low-income communities has the potential to
exert a beneficial effect and improve or maintain inflam-
matory biomarkers profiles, assisting in the prevention of
chronic diseases. However, a larger randomized controlled
trial needs to be conducted to confirm or refute these
suggestive findings.
5. Conclusion
Themajor finding of the present studywas that a public health
exercise intervention was effective in decreasing CRP and
TNF𝛼 levels and maintaining IL10, IL6, and insulin levels
over 1 year. Developing and delivering a community-based,
public health exercise intervention like SARC could be a
viable initiative to promote health at the public health level.
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